Référentiel de la Société francophone du diabète (SFD) : vaccination chez la personne diabétique

Sultan, Ariane; Bauduceau, B.; Baron, S.; Brunot, Sophie; Casanova, Ludovic; Chaumeil, Claude; Galtier, Florence; Lecointre, Brigitte; Morand, Aurélie; Phirmis, Laura; Sallerin, Brigitte; Wazières, B. de; Wyplosz, Benjamin

doi:10.1016/j.mmm.2020.01.010

Cited by 2 publications

(3 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, in Lomé cases of urinary tract infections occur predominantly in males (58.82%) with a sex ratio of 1.43 and the average age of patients was 55.87 ± 12.48 years with extremes of 22 and 93 years [32]. Renal failure and diabetes have a high prevalence in the elderly, one of the most important common consequences of which is urinary tract infection [34][35][36]. Bacterial infections are however, a widespread problem in health systems worldwide, particularly in African countries.…”

Section: Discussionmentioning

confidence: 99%

Spread and antibiotic resistance profile of pathogens isolated from human and hospital wastewater in Ouagadougou

Abasse¹,

Boukaré²,

Sampo³

et al. 2021

Microbes and Infectious Diseases

View full text Add to dashboard Cite

Background:The discharge of improperly treated hospital landfill presents an enormous public health risk. In Burkina Faso, the management of hospital's wastewaters and the current antibiotic susceptibility of clinically relevant isolates need to be determined, because the multi-drug resistant isolates have been previously described in hospital settings. The aim of this study was to determine antibiotic resistance profile of isolates circulating in Ouagadougou. Methods: The biochemical characterization of the isolates was carried out by tests from the API 20E test and completed with molecular characterization by simple polyemerase chain reaction (PCR). Antibiotic susceptibility of the isolates was determined using the recommendations of CA-SFM 2019. Results: The hospital wastewaters do not undergo any treatment before been discharged into the environment. A total of 171 presumed isolates of Salmonella spp, Pseudomonas spp, and Escherichia coli were identified in this study. These isolates derived from environment (n=19) and clinical (n=152). These isolates were resistant to amoxicillin + clavulanic acid (95.32%), cefoxitin (72.51%), ceftazidime (78.94%), cefepime (80.71%), tobramycin (59.64%), gentamicin (42.10%), nalidixic acid (68.42%), norfloxacin (59.06%), ciprofloxacin (56.14%), imipenem (0.00%), chloramphenicol (26.31%), and colistin (77.77%). Somewhere else, 46 presumptive Staphylococcus aureus were resistant to vancomycin (30.43%), oxacillin (13.04%), penicillin G (89.13%), ceftriaxone (15.21%), cefoxitin (2.73%),t (36.95%), kanamycin (30.43%), ciprofloxacin (15.21%), norfloxacin (43.47%), Tetracycline (56.52%), chloramphenicol (13.04%), and Fosfomycin (2.73%). Conclusion: The hospital wastewaters harbour a variety of pathogens, most of which are resistant to several families of antibiotics.

show abstract

Section: Discussionmentioning

confidence: 99%

Spread and antibiotic resistance profile of pathogens isolated from human and hospital wastewater in Ouagadougou

Abasse¹,

Boukaré²,

Sampo³

et al. 2021

Microbes and Infectious Diseases

View full text Add to dashboard Cite

show abstract

“…Yet, these infections can be prevented by vaccination, which has been recommended by various national health services and diabetology societies [5,[8][9][10][11][12]. The recommendations specify that certain vaccinations should be mandatory for the general adult population (diphtheria, pertussis) and that others should be given to people living with diabetes (influenza, pneumococcal, hepatitis B, meningococcal, COVID-19, measles, mumps and rubella, and varicella) or those between 65 and 74 years old, independently of diabetes (herpes zoster) [4,[13][14][15][16][17][18][19][20]. Despite these recommendations, a lack of vaccination coverage has been observed.…”

Section: Introductionmentioning

confidence: 99%

“…For example, seasonal influenza vaccine coverage among people with diabetes ranges from 32% to 85% depending on the country, age group, and season [21]. There are only limited data on the pneumococcal vaccine coverage of diabetic patients, with the estimations ranging between 20% and 30% [14]. The obstacles to vaccination are multiple and of various origins [22][23][24], which suggests that the input and skills of all health professionals across primary, community, and specialist care are essential to provide high quality care for people with diabetes.…”

Section: Introductionmentioning

confidence: 99%

Impact of Hospitalization in an Endocrinology Department on Vaccination Coverage in People Living with Diabetes: A Real-Life Study

et al. 2022

Self Cite

View full text Add to dashboard Cite

Background and Objectives: Vaccination coverage is suboptimal in people living with diabetes. The objectives of this study were to determine the impact of hospitalization on vaccination coverage and the variables associated with vaccination during hospital stay. Materials and Methods: This observational study was conducted from May 2019 to December 2019 in the Endocrinology-Nutrition-Diabetes Department of the University Hospital of Montpellier, France. This department encompasses three medical units, two of which have a full-time clinical pharmacist involved in the multidisciplinary management of patients. All adult diabetic patients who completed a questionnaire about vaccines were prospectively included by a clinical pharmacist and followed until department discharge. Coverage at the time of admission for the tetanus, diphtheria, pertussis (Tdap), pneumococcal, influenza, and herpes zoster vaccines was assessed from patient interviews and/or contact with the general practitioner and/or with the community pharmacist. Multivariable logistic regression analysis was performed to identify the factors associated with a vaccination update during the hospital stay. Results: A total of 222 patients were included (mean age: 59.4 years, 68.5% type 2 diabetes). Vaccination coverage increased by 26.7% (47.3% to 59.9%), 188.0% (10.8% to 31.1%) and 8.9% (45.9% to 50.0%), respectively, for the Tdap, pneumococcal and influenza vaccines during hospital stay. Female sex, admission to a diabetes care unit with a full-time pharmacist, favorable feelings about vaccination, unknown immunization coverage for pneumococcal vaccines, and evaluation and recording of vaccine coverage at admission in the patient medical records were associated with at least one vaccination during hospital stay. Conclusions: Our real-life study highlights that hospitalization and multidisciplinary management (i.e., physician-pharmacist) may be key points in the diabetes care pathway to improve vaccination coverage, especially for patients with advanced diabetes and comorbidities (study registered on ClinicalTrials.gov, NCT04391088).

show abstract

Référentiel de la Société francophone du diabète (SFD) : vaccination chez la personne diabétique

Cited by 2 publications

References 47 publications

Spread and antibiotic resistance profile of pathogens isolated from human and hospital wastewater in Ouagadougou

Spread and antibiotic resistance profile of pathogens isolated from human and hospital wastewater in Ouagadougou

Impact of Hospitalization in an Endocrinology Department on Vaccination Coverage in People Living with Diabetes: A Real-Life Study

Contact Info

Product

Resources

About